Moderna along with other four companies currently developing coronavirus vaccines has a date with Congress on July 21.
Officials from those companies will field questions from the committee’s oversight and investigations subcommittee on the current state of their vaccine development processes.
In its official announcement, the committee said that “[w]e look forward to hearing from each of the companies about their research and development efforts, safety and efficacy standards and their ongoing preparations to manufacture and distribute an eventual vaccine.”
The committee promised that additional details about the hearings, which are scheduled for Tuesday, July 21, will be provided the week before they take place.
Moderna, AstraZeneca, Johnson & Johnson, Merck, and Pfizer are not the only biotech or pharmaceutical companies developing the coronavirus vaccine candidate. However, they are the five tapped to participate in the government’s Warp Speed Program, in which it’s contributing resources to helping the most promising vaccine candidates through the development process.